BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Szegeczki V, Bauer B, Jüngling A, Fülöp BD, Vágó J, Perényi H, Tarantini S, Tamás A, Zákány R, Reglődi D, Juhász T. Age-related alterations of articular cartilage in pituitary adenylate cyclase-activating polypeptide (PACAP) gene-deficient mice. Geroscience 2019;41:775-93. [PMID: 31655957 DOI: 10.1007/s11357-019-00097-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Ko KR, Lee H, Han S, Ahn W, Kim DK, Kim I, Jung BS, Lee S. Substance P, A Promising Therapeutic Target in Musculoskeletal Disorders. IJMS 2022;23:2583. [DOI: 10.3390/ijms23052583] [Reference Citation Analysis]
2 Hajdú T, Kovács P, Zsigrai E, Takács R, Vágó J, Cho S, Sasi-Szabó L, Becsky D, Keller-Pinter A, Emri G, Rácz K, Reglodi D, Zákány R, Juhász T. Pituitary Adenylate Cyclase Activating Polypeptide Has Inhibitory Effects on Melanoma Cell Proliferation and Migration In Vitro. Front Oncol 2021;11:681603. [PMID: 34616669 DOI: 10.3389/fonc.2021.681603] [Reference Citation Analysis]
3 D'Amico AG, Maugeri G, Vanella L, Pittalà V, Reglodi D, D'Agata V. Multimodal Role of PACAP in Glioblastoma. Brain Sci 2021;11:994. [PMID: 34439613 DOI: 10.3390/brainsci11080994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
4 Jungling A, Reglodi D, Maasz G, Zrinyi Z, Schmidt J, Rivnyak A, Horvath G, Pirger Z, Tamas A. Alterations of Nigral Dopamine Levels in Parkinson's Disease after Environmental Enrichment and PACAP Treatment in Aging Rats. Life (Basel) 2021;11:35. [PMID: 33429934 DOI: 10.3390/life11010035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Pöstyéni E, Kovács-Valasek A, Dénes V, Mester A, Sétáló G Jr, Gábriel R. PACAP for Retinal Health: Model for Cellular Aging and Rescue. Int J Mol Sci 2021;22:E444. [PMID: 33466261 DOI: 10.3390/ijms22010444] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Perényi H, Szegeczki V, Horváth G, Hinnah B, Tamás A, Radák Z, Ábrahám D, Zákány R, Reglodi D, Juhász T. Physical Activity Protects the Pathological Alterations of Alzheimer's Disease Kidneys via the Activation of PACAP and BMP Signaling Pathways. Front Cell Neurosci 2020;14:243. [PMID: 32922265 DOI: 10.3389/fncel.2020.00243] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
7 Szegeczki V, Horváth G, Perényi H, Tamás A, Radák Z, Ábrahám D, Zákány R, Reglodi D, Juhász T. Alzheimer's Disease Mouse as a Model of Testis Degeneration. Int J Mol Sci 2020;21:E5726. [PMID: 32785075 DOI: 10.3390/ijms21165726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Lauretta G, Ravalli S, Szychlinska MA, Castorina A, Maugeri G, D'Amico AG, D'Agata V, Musumeci G. Current knowledge of pituitary adenylate cyclase activating polypeptide (PACAP) in articular cartilage. Histol Histopathol 2020;35:1251-62. [PMID: 32542641 DOI: 10.14670/HH-18-233] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Kovacs AK, Atlasz T, Werling D, Szabo E, Reglodi D, Toth GK. Stability Test of PACAP in Eye Drops. J Mol Neurosci 2021;71:1567-74. [PMID: 32323126 DOI: 10.1007/s12031-020-01532-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Li FX, Xu F, Lin X, Wu F, Zhong JY, Wang Y, Guo B, Zheng MH, Shan SK, Yuan LQ. The Role of Substance P in the Regulation of Bone and Cartilage Metabolic Activity. Front Endocrinol (Lausanne) 2020;11:77. [PMID: 32180759 DOI: 10.3389/fendo.2020.00077] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]